Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type
Clinical Lymphoma Myeloma and Leukemia · 2026-11 · 26 (11) · e1294-e1299
DOI: 10.1016/j.clml.2026.08.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-11. Verfasst von Cristina A Perez-Witte und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology/Oncology, UCSF Benioff Children's Hospital, San Francisco, CA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Swim Across America.
Abstract (Originalsprache)
INTRODUCTION: Acute leukemia diagnosed during infancy is associated with inferior survival compared with leukemia diagnosed in older children, but outcomes during the first 6 months of life remain poorly characterized. PATIENTS AND METHODS: We performed a retrospective population-based cohort study using the Surveillance, Epidemiology, and End Results (SEER) database to evaluate overall survival among children diagnosed with first primary acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) during the first 6 months of life. Overall survival was estimated using the Kaplan-Meier method and multivariable Cox regression. RESULTS: A total of 384 children were included, comprising 197 (51.3%) with AML and 187 (48.7%) with ALL. Children with AML were younger at diagnosis than those with ALL (median age, 1 vs. 3 months; P < .001). Five-year overall survival was 59.8% (95% CI, 52.3%-66.4%) for AML and 42.5% (95% CI, 34.8%-50.0%) for ALL (log-rank P = .014). After adjustment for age at diagnosis, sex, race, and Hispanic ethnicity, AML was associated with a lower hazard of death than ALL (adjusted hazard ratio [HR], 0.57; 95% CI, 0.42-0.78; P < .001). Increasing age at diagnosis independently predicted improved survival (adjusted HR per month, 0.82; 95% CI, 0.75-0.90; P < .001). Despite superior long-term survival, early mortality was more frequent in AML than ALL (14.7% vs. 7.0%; P = .015). CONCLUSIONS: These findings identify age and leukemia type as independent predictors of survival during the first 6 months of life and provide a population-based benchmark for evaluating emerging biologically directed therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Hematology/Oncology, UCSF Benioff Children's Hospital, San Francisco, CA.
- Pediatric Hematology/Oncology, UCSF Benioff Children's Hospital, San Francisco, CA; Division of Allergy, Immunology, and BMT, UCSF Benioff Children's Hospitals, San Francisco, CA.
- College of Science and Mathematics, Cal Poly, San Luis Obispo, CA.
- Division of Allergy, Immunology, and BMT, UCSF Benioff Children's Hospitals, San Francisco, CA.
- Pediatric Hematology/Oncology, UCSF Benioff Children's Hospital, San Francisco, CA. Electronic address: goldsbyr@ucsf.edu.
Förderung
- NCI NIH HHS
- Swim Across America
Zitieren
APA
Perez-Witte, C. A., Wu, N., Pauerstein, P. T., Burke, L. M., Winestone, L. E., & Goldsby, R. E. (2026). Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type. Clinical Lymphoma Myeloma and Leukemia, 26(11), e1294-e1299. https://doi.org/10.1016/j.clml.2026.08.013
Vancouver
Perez-Witte CA, Wu N, Pauerstein PT, Burke LM, Winestone LE, Goldsby RE. Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type. Clinical Lymphoma Myeloma and Leukemia. 2026;26(11):e1294-e1299. doi:10.1016/j.clml.2026.08.013
BibTeX
@article{PerezWitte2026,
author = {Perez-Witte, Cristina A and Wu, Natalie and Pauerstein, Philip T and Burke, Lilianne M and Winestone, Lena E and Goldsby, Robert E},
title = {Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {11},
pages = {e1294--e1299},
doi = {10.1016/j.clml.2026.08.013}
}
EUVIMED